- Home
- MBWM vs QURE Comparison
MBWM vs QURE Comparison
Compare MBWM & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- QURE
- Stock Information
- Founded
- MBWM 1997
- QURE 1998
- Country
- MBWM United States
- QURE Netherlands
- Employees
- MBWM N/A
- QURE N/A
- Industry
- MBWM Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- MBWM Finance
- QURE Health Care
- Exchange
- MBWM Nasdaq
- QURE Nasdaq
- Market Cap
- MBWM 763.4M
- QURE 866.3M
- IPO Year
- MBWM 1997
- QURE 2007
- Fundamental
- Price
- MBWM $49.25
- QURE $16.33
- Analyst Decision
- MBWM Buy
- QURE Strong Buy
- Analyst Count
- MBWM 4
- QURE 10
- Target Price
- MBWM $53.63
- QURE $36.90
- AVG Volume (30 Days)
- MBWM 55.6K
- QURE 814.7K
- Earning Date
- MBWM 10-14-2025
- QURE 07-29-2025
- Dividend Yield
- MBWM 3.00%
- QURE N/A
- EPS Growth
- MBWM N/A
- QURE N/A
- EPS
- MBWM 5.03
- QURE N/A
- Revenue
- MBWM $228,384,000.00
- QURE $14,337,000.00
- Revenue This Year
- MBWM $10.34
- QURE N/A
- Revenue Next Year
- MBWM $11.93
- QURE $301.10
- P/E Ratio
- MBWM $9.79
- QURE N/A
- Revenue Growth
- MBWM 3.70
- QURE N/A
- 52 Week Low
- MBWM $37.76
- QURE $4.45
- 52 Week High
- MBWM $52.98
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- MBWM 60.30
- QURE 63.97
- Support Level
- MBWM $47.37
- QURE $15.28
- Resistance Level
- MBWM $50.23
- QURE $16.68
- Average True Range (ATR)
- MBWM 1.26
- QURE 0.79
- MACD
- MBWM 0.36
- QURE 0.13
- Stochastic Oscillator
- MBWM 81.65
- QURE 87.59
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.